The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIronveld Regulatory News (IRON)

Share Price Information for Ironveld (IRON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0745
Bid: 0.074
Ask: 0.075
Change: 0.0015 (2.05%)
Spread: 0.001 (1.351%)
Open: 0.073
High: 0.0745
Low: 0.073
Prev. Close: 0.073
IRON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Loan Facilities Agreement

3 Feb 2020 07:00

RNS Number : 6568B
Ironveld PLC
03 February 2020
 

IRONVELD PLC

("Ironveld" or the "Company")

 

Loan Facilities Agreement

Ironveld is pleased to announce that the Company has entered into definitive agreements with a consortium of high net worth investors (the "Lenders") and existing shareholders to raise, in aggregate, approximately £260,000 through short term unsecured loan facilities ("Loan Facilities"). It is intended that the proceeds from the Loan Facilities will be used for working capital purposes while the Company continues to engage with potential funders for its high purity iron powder, vanadium and titanium project in South Africa.

Highlights:

·; Total sum available under the Loan Facilities is £260,000.

 

·; The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election until the full £260,000 has been lent.

 

·; Each tranche of the loan will mature six months from the date of receipt of funds by Ironveld.

 

·; The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

 

·; The Lenders may elect to receive any interest payments due under the Loan Facilities in ordinary shares at a price of 1p each.

 

·; Participation of Ironveld's largest shareholder and Chairman in the Loan Facilities demonstrates support.

 

The Board believes that the draw down on the Loan Facilities will provide the Company with sufficient cash resources to enable it to operate until May 2020, by which time it hopes to have secured a transaction with a strategic financing partner.

Martin Eales, Chief Executive Officer, commented:

"I have been highly encouraged by the discussions we have had so far with parties potentially interested in participating in the financing for our project. Until we are in a position to conclude this financing, the Loan Facilities announced today are extremely helpful in ensuring that our modest short-term working capital requirements are met.

"Additionally, any issue of new shares via the Warrants or in interest payments will be at a substantial 60 per cent premium to the underlying share price, thereby minimising the potential dilution for shareholders."

Terms and Conditions of the Loan Facilities

The total sum available under the Loan Facilities is £260,000. The Loan Facilities have a six month term from draw down of funds, are unsecured and carry an interest rate of eight per cent per year. The Lenders, at their sole discretion, may elect to receive the due interest in shares of Borrower with a deemed price of 1p per share, such election to be made by Lenders at least 10 business days before the Repayment Date. The interest shall accrue daily and shall be payable on the Repayment Date.

The Loan will be disbursed in tranches: £110,000 by 14 February 2020 and three further monthly tranches of £50,000 at the Company's election on the 20th of each month thereafter until the full £260,000 has been lent.

If the Company fails to make any payment due on the due date for payment, interest on the unpaid amount shall accrue daily, from the date of non-payment to the date of actual payment (both before and after judgment), at an additional five per cent.

The Company has issued a total of 26,000,000 warrants to subscribe for ordinary shares in the Company at a subscription price of 1p per share to the Lenders, pro rata to the amount of each loan (the "Warrants"). The Warrants have a two year life and Lenders may use outstanding balances under the Loan Facilities to exercise Warrants.

Should the Company carry out a capital reorganisation, subdivision or consolidation during the warrant term, the Company will redenominate the warrant strike price to reflect the pre-reorganisation terms.

Related Party Transaction

Tracarta Limited and Giles Clarke have contributed £50,000 and £10,000 respectively to the Loan Facilities and been issued with 5,000,000 and 1,000,000 Warrants respectively. Tracarta Limited holds 12.27 per cent of the issued share capital in the Company, and Giles Clarke is the Company's Chairman. Therefore both are related parties for the purposes of the AIM Rules for Companies. Accordingly, the participation of the Related Parties in the Loan Facilities constitutes a related party transaction pursuant to Rule 13 of the AIM Rules for Companies.

The independent directors of Ironveld, being all those except Giles Clarke, having consulted with the Company's Nominated Adviser finnCap, consider that the terms of the Loan Facilities are fair and reasonable insofar as the Company's shareholders are concerned.

The information communicated in this announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No. 596/2014.

 

For further information, please contact:

Ironveld plc

Giles Clarke, Chairman

Martin Eales, Chief Executive Officer

 

 

c/o Blytheweigh

+44 20 7138 3204

 

finnCap (Nomad and Broker)

Christopher Raggett / Hannah Boros

 

 

+44 20 7220 0500

Blytheweigh

Tim Blythe / Megan Ray

 

+44 20 7138 3204

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
AGRUPUGGPUPUGUP
Date   Source Headline
26th Jan 20174:18 pmRNSTR-1: Notification of Major Interest in Shares
5th Jan 201712:05 pmRNSResult of AGM
21st Dec 201611:06 amRNSNotice of AGM
7th Dec 20167:00 amRNSFinal results for the year ended 30 June 2016
22nd Nov 20167:00 amRNSInvestor evening - 1 December 2016
14th Nov 201611:45 amRNSResult of General Meeting
1st Nov 20167:00 amRNSTotal Voting Rights and Blocklisting Return
26th Oct 20161:21 pmRNSPlacing to raise c.£1.8 million and Notice of GM
6th Oct 20167:00 amRNSProject Finance Facilities and Offtake
2nd Sep 20169:28 amRNSConversion of consultants fees into equity
7th Jun 20167:00 amRNSVanadium Slag Offtake Agreement Signed
20th May 20167:00 amRNSOfftake Agreement and Final Approvals
30th Mar 20167:00 amRNSInterim Results
23rd Mar 201611:06 amRNSHolding(s) in Company
28th Jan 20167:00 amRNSGrant of Share Options
27th Jan 20164:03 pmRNSConversion of Directors' fees into equity
18th Dec 201510:00 amRNSResult of AGM
18th Dec 20157:00 amRNSFinal Approvals and Company Update
23rd Nov 20157:00 amRNSFinal Results
23rd Oct 20157:00 amRNSBlocklisting Return
5th Oct 20157:00 amRNSFunding update & Senior Management Appointment
21st Aug 20153:03 pmRNSHolding(s) in Company
4th Aug 20157:00 amRNSConversion of consultants fees into equity
3rd Aug 20157:00 amRNSOperational Update
9th Jul 20157:00 amRNSConversion of Directors' fees into equity
7th Jul 20157:00 amRNSAppointment of Chief Financial Officer
29th Jun 201510:11 amRNSHolding(s) in Company
22nd Jun 20157:00 amRNSEnvironmental Impact Assessment approved
18th Jun 20157:00 amRNSPlacing and Project Development Update
23rd Apr 20155:30 pmRNSBlocklisting Return
30th Mar 20157:00 amRNSHalf Yearly Report
26th Mar 20157:00 amRNSMining Right Application submitted
19th Mar 20157:00 amRNSDirectorate Change
4th Mar 20157:00 amRNSConversion of consultants fees into equity
2nd Mar 20157:00 amRNSGranting of Mining Right
17th Feb 20157:00 amRNSCritical Infrastructure Programme Application
9th Jan 20155:16 pmRNSConversion of Directors' fees into equity
29th Dec 201411:01 amRNSResult of AGM
15th Dec 20147:00 amRNSHolding(s) in Company
11th Dec 20147:00 amRNSDirector/PDMR Shareholding
9th Dec 20148:46 amRNSDirector's Dealing
5th Dec 20147:00 amRNSFinal Results for 12 Month Period Ended 30/06/2014
3rd Dec 20147:00 amRNSPlacing to raise £750,000
23rd Oct 201412:45 pmRNSBlocklisting Return
22nd Oct 20147:00 amRNSSubmission of CIP Application
21st Oct 20147:00 amRNSBroad-Based Black Economic Empowerment structures
18th Sep 20147:00 amRNSApproval of 12I Tax Allowance
15th Aug 20147:00 amRNSEnvironmental Scoping Report
13th Aug 20147:00 amRNS12I Tax Allowance Incentive Application
28th Apr 20147:00 amRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.